Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Disarib |
Trade Name | |
Synonyms | |
Drug Descriptions |
Disarib is a small molecule inhibitor of BCL2, which targets the BH1 domain of BCL2, thereby interfering with the interaction between BCL2 and BAK, and subsequently, leading to apoptosis (PMID: 28223017). |
DrugClasses | BCL2 inhibitor 27 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Disarib | Disarib | 0 | 0 |
Disarib + Paclitaxel | Disarib Paclitaxel | 0 | 0 |